Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

IQVIA Biotech’s Sockalingam On Clinical Research Virtualization In APAC

Executive Summary

In this audio interview, the head of IQVIA Biotech (Japan-Asia Pacific) talks to Scrip on a range of aspects around digitalization and virtualization of clinical research in the region, including sharply reduced site contracting timelines. He also touches on the digital product launch efforts that are currently a reality in several markets.

Dr Senthil Sockalingam, head, IQVIA Biotech, Japan-Asia Pacific (JAPAC) and chief medical officer, APAC, spoke to Scrip on trends and opportunities in the clinical research segment, partnering/outsourcing approaches and digitalization efficiencies, driven by the pandemic.

Rapid "virtualization" of the trials segment, how the regulatory framework in certain APAC markets is still catching up in this area, and adoption of telemedicine are some of the other key issues he delves into in this audio interview.

Sockalingam, a physician by training, also declared that artificial intelligence is the “new stethoscope or echocardiogram” and will only aid - not replace - doctors. There’s no need for them to become “nervous” he said.

Podcast Time Stamps

00:08 Introduction

00:58 IQVIA Biotech’s Latest Expansion In Japan/Asia Pacific

04:40 Diverse APAC Region, Oncology/Immunology Focus Of Biotechs, Partnering Models

11.53 Pandemic-Driven Virtualization Of Trials, Site Contracting Timelines

17:57 Digital Launch Efforts, Democratization Of Healthcare Providers’ Access To Information

21:25 Evolving Patient Journey

24:16 AI In Drug Development,Treatment

These and all our other podcasts are available on the Informa Pharma Intelligence channel on Apple Podcasts, Google Podcasts, SoundCloud and TuneIn - and also now on Spotify Podcasts - and via smart speakers if one of these platforms has been set up as your default podcast provider. 

Related Stories:

https://scrip.pharmaintelligence.informa.com/SC144394/More-Small-Biotechs-Are-Launching-Drugs-On-Their-Own

https://scrip.pharmaintelligence.informa.com/SC143436/Indian-Trials-Recover-Amid-Lingering-Pandemic-Challenges

https://scrip.pharmaintelligence.informa.com/SC144125/AI-And-Tackling-Challenges-In-Clinical-Medicine

https://scrip.pharmaintelligence.informa.com/SC144058/Chinas-Internet-Hospitals-And-New-Commercial-Models-For-Pharma

https://scrip.pharmaintelligence.informa.com/SC142404/Commercial-Models-Shifting-As-Pharma-Mulls-Digital-First-Launches

https://scrip.pharmaintelligence.informa.com/SC144238/ISCRs-Davis-On-Pandemic-Adaptations-Value-Of-MultiRegional-Trials


Topics

Related Companies

UsernamePublicRestriction

Register

SC144488

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel